Stock AEZS AETERNA ZENTARIS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Aeterna Zentaris Inc.

Equities

AEZS

CA0079755017

Biotechnology & Medical Research

Market Closed - Toronto S.E.
Other stock markets
 10:05:33 2024-04-26 EDT 		5-day change 1st Jan Change
2.65 CAD -0.38% Intraday chart for Aeterna Zentaris Inc. -0.75% +3.11%
04-03 North American Morning Briefing : Powell Awaited -2- DJ
03-28 Ceapro Brief: Parties anticipate completing Transaction in Q2 2024, subject to obtaining all required approvals and satisfying all required conditions MT

Business Summary

Aeterna Zentaris Inc. is a Canada-based specialty biopharmaceutical company. The Company is developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. The Company's lead product, macimorelin (Macrilen, Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also leveraging the clinical and compelling safety profile of macimorelin to develop it for the diagnosis of childhood-onset growth hormone deficiency (CGHD). The Company is engaged in the development of its therapeutic asset and has established a pre-clinical development pipeline to potentially address unmet medical needs across a number of indications, including neuromyelitis optica spectrum disorder (NMOSD), Parkinson's disease (PD), hypoparathyroidism and amyotrophic lateral sclerosis (ALS). Its therapeutic development pipeline includes AIM Biologicals, AEZS-150 and AEZS-130.

Number of employees: 12

Sales per Business

CAD in Million2022Weight2023Weight Delta
Biopharmaceutical
100.0 %
7 100.0 % 6 100.0 % -17.32%

Sales per region

CAD in Million2022Weight2023Weight Delta
Switzerland
96.0 %
7 95.7 % 6 96.0 % -17.04%
Ireland
2.7 %
0 1.5 % 0 2.7 % +54.25%
Other
1.1 %
0 0.1 % 0 1.1 % +1,558.79%
Denmark
0.2 %
0 2.8 % 0 0.2 % -92.87%

Managers

Managers TitleAgeSince
Klaus Wolfgang Paulini CEO
 Chief Executive Officer 60 19-10-03
Giuliano La Fratta DFI
 Director of Finance/CFO - 22-01-23
Patricia Zahn ADM
 Chief Administrative Officer - 15-09-30
Nicola Ammer CTO
 Chief Tech/Sci/R&D Officer - 14-01-31
Michael Teifel CTO
 Chief Tech/Sci/R&D Officer - 03-12-31
Matthias Gerlach PRN
 Corporate Officer/Principal - 00-12-31
Eckhard Guenther PRN
 Corporate Officer/Principal - 05-12-31

Members of the board

Members of the board TitleAgeSince
Gilles Gagnon BRD
 Director/Board Member 70 19-12-31
Peter Edwards BRD
 Director/Board Member 62 20-05-14
Dennis Turpin BRD
 Director/Board Member - 21-05-04
Carolyn Egbert CHM
 Chairman - 12-07-31
Klaus Wolfgang Paulini CEO
 Chief Executive Officer 60 19-10-03

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 4,855,876 4,664,308 ( 96.05 %) 0 96.05 %

Shareholders

NameEquities%Valuation
Morgan Stanley Capital Services LLC
0.3311 %
16,080 0.3311 % 35 215 $
Citadel Securities GP LLC
0.2060 %
10,002 0.2060 % 21 904 $
Klaus Wolfgang Paulini
0.0865 %
4,200 0.0865 % 9 198 $
Edmond De Rothschild Holding SA /13F Subfiler/
0.0824 %
4,000 0.0824 % 8 760 $
Group One Trading LP
0.0618 %
2,999 0.0618 % 6 568 $
Dennis Turpin
0.0264 %
1,280 0.0264 % 2 803 $
Carolyn Egbert
0.0263 %
1,276 0.0263 % 2 794 $
JPMorgan Securities LLC
0.0174 %
843 0.0174 % 1 846 $
RBC Dominion Securities, Inc.
0.0136 %
658 0.0136 % 1 441 $
National Bank Financial, Inc.
0.006343 %
308 0.006343 % 675 $

Company contact information

Æterna Zentaris, Inc.

222 Bay Street Suite 3000

M5K 1E7, Toronto

+

http://www.zentaris.com
address Aeterna Zentaris Inc.(AEZS)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per region

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
AETERNA ZENTARIS INC. Stock Aeterna Zentaris Inc.
+3.11% 9.4M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. AEZS Stock
  4. Company Aeterna Zentaris Inc.